Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Brophy

Showing results (121-130 of 245) with videos related to

Pageof 25
Sort By:
Interdisciplinary Cardiovascular and Thoracic Surgery|July 2, 2024
Composite end points and competing risks analysisVictor Dayan, Stuart W Grant, James M Brophy, et al.
BMJ Open|June 10, 2022
Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort studyJulie Rouette, Emily G McDonald, Tibor Schuster, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2017
Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposureMichèle Bally, Marie-Eve Beauchamp, Michal Abrahamowicz, et al.
The American Journal of Medicine|December 22, 2018
The ReplyTodd C Lee, Rodrigo B Cavalcanti, Emily G McDonald, et al.
JAMA|April 5, 2012
Oral fluoroquinolones and the risk of retinal detachmentMahyar Etminan, Farzin Forooghian, James M Brophy, et al.
The Canadian Journal of Cardiology|September 26, 2020
Distorting Effect of Immortal Time Bias on the Association Between Catheter Ablation for Atrial Fibrillation and Incident Stroke: Caveat EmptorMichelle Samuel, James M Brophy, Laura D'Aronco, et al.
BMJ Open|January 14, 2025
Impact of the COVID-19 pandemic on primary care for hypertension in the UK: a population-based cohort studyKyle Johnson, Sarah Beradid, James M Brophy, et al.
Chest|August 9, 2012
Bronchodilator use and the risk of arrhythmia in COPD: part 1: Saskatchewan cohort studyMachelle Wilchesky, Pierre Ernst, James M Brophy, et al.
Chest|August 9, 2012
Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohortMachelle Wilchesky, Pierre Ernst, James M Brophy, et al.
British Journal of Clinical Pharmacology|September 13, 2025
Trends in first-line monotherapy and combination therapy for hypertension in UK primary careKyle Johnson, Sarah Beradid, James M Brophy, et al.
Pageof 25

Showing results (121-130 of 245) with videos related to

Sort By:
Pageof 25
Interdisciplinary Cardiovascular and Thoracic Surgery|July 2, 2024
Composite end points and competing risks analysisVictor Dayan, Stuart W Grant, James M Brophy, et al.
BMJ Open|June 10, 2022
Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort studyJulie Rouette, Emily G McDonald, Tibor Schuster, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2017
Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposureMichèle Bally, Marie-Eve Beauchamp, Michal Abrahamowicz, et al.
The American Journal of Medicine|December 22, 2018
The ReplyTodd C Lee, Rodrigo B Cavalcanti, Emily G McDonald, et al.
JAMA|April 5, 2012
Oral fluoroquinolones and the risk of retinal detachmentMahyar Etminan, Farzin Forooghian, James M Brophy, et al.
The Canadian Journal of Cardiology|September 26, 2020
Distorting Effect of Immortal Time Bias on the Association Between Catheter Ablation for Atrial Fibrillation and Incident Stroke: Caveat EmptorMichelle Samuel, James M Brophy, Laura D'Aronco, et al.
BMJ Open|January 14, 2025
Impact of the COVID-19 pandemic on primary care for hypertension in the UK: a population-based cohort studyKyle Johnson, Sarah Beradid, James M Brophy, et al.
Chest|August 9, 2012
Bronchodilator use and the risk of arrhythmia in COPD: part 1: Saskatchewan cohort studyMachelle Wilchesky, Pierre Ernst, James M Brophy, et al.
Chest|August 9, 2012
Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohortMachelle Wilchesky, Pierre Ernst, James M Brophy, et al.
British Journal of Clinical Pharmacology|September 13, 2025
Trends in first-line monotherapy and combination therapy for hypertension in UK primary careKyle Johnson, Sarah Beradid, James M Brophy, et al.
Pageof 25